State dependent posterior hippocampal volume increases in patients with major depressive disorder

2011 ◽  
Vol 135 (1-3) ◽  
pp. 405-409 ◽  
Author(s):  
Ingrid Schermuly ◽  
Dominik Wolf ◽  
Klaus Lieb ◽  
Peter Stoeter ◽  
Andreas Fellgiebel
2020 ◽  
Vol 87 (9) ◽  
pp. S257
Author(s):  
Sneha Chenji ◽  
Emily Cox ◽  
Natalia Jaworska ◽  
Rose Swansburg ◽  
Frank MacMaster

2013 ◽  
Vol 47 (3) ◽  
pp. 299-306 ◽  
Author(s):  
Justin A. Cobb ◽  
Joy Simpson ◽  
Gouri J. Mahajan ◽  
James C. Overholser ◽  
George J. Jurjus ◽  
...  

2015 ◽  
Vol 5 (11) ◽  
pp. e676-e676 ◽  
Author(s):  
E Henje Blom ◽  
L K M Han ◽  
C G Connolly ◽  
T C Ho ◽  
J Lin ◽  
...  

2013 ◽  
Vol 25 (4) ◽  
pp. 206-214 ◽  
Author(s):  
Jamila Ahdidan ◽  
Leslie Foldager ◽  
Raben Rosenberg ◽  
Anders Rodell ◽  
Poul Videbech ◽  
...  

ObjectiveThe main aim of the present study was to replicate a previous finding in major depressive disorder (MDD) of association between reduced hippocampal volume and the long variant of the di- and triallelic serotonin transporter polymorphism inSLC6A4on chromosome 17q11.2. Secondarily, we also hypothesised that 5-HTTLPR may be a risk factor for MDD.MethodsQuantitative magnetic resonance imaging (MRI) of the hippocampus was studied in 23 inpatients suffering from MDD and in 33 healthy controls. Normalised volumetric MRI data of hippocampus were assessed with adjustment for total brain volume and tensor-based morphometry was used to elucidate structural brain differences. A triallelic genetic marker resulting from twoSLC6A4promoter region polymorphisms, 5-HTTLPR and rs25531, was analysed for association with MDD and quantitative traits.ResultsHealthy controls had a smaller relative hippocampal volume (relative to brain size) but a larger total brain volume compared with patients with MDD. For patients compared with healthy controls, atrophy was found in the right temporal lobe and pons medulla. Allele and genotype frequencies were strikingly different from the previous study that we aimed to replicate, and no significant associations with the serotonin transporter polymorphism were found.ConclusionsThe present quantitative and morphometric MRI study was not able to replicate the previous finding of association between reduced hippocampal volume in depressed patients and the serotonin transporter polymorphism.


2013 ◽  
Vol 9 (9) ◽  
pp. 1404-1412 ◽  
Author(s):  
Chang-hyun Park ◽  
Sheng-Min Wang ◽  
Hae-Kook Lee ◽  
Yong-Sil Kweon ◽  
Chung Tai Lee ◽  
...  

2004 ◽  
Vol 56 (2) ◽  
pp. 101-112 ◽  
Author(s):  
Meena Vythilingam ◽  
Eric Vermetten ◽  
George M Anderson ◽  
David Luckenbaugh ◽  
Eric R Anderson ◽  
...  

2010 ◽  
Vol 68 (9) ◽  
pp. 847-853 ◽  
Author(s):  
Katarina Dedovic ◽  
Veronika Engert ◽  
Annie Duchesne ◽  
Sonja Damika Lue ◽  
Julie Andrews ◽  
...  

2016 ◽  
Vol 46 (11) ◽  
pp. 2313-2328 ◽  
Author(s):  
M. M. Rive ◽  
M. W. J. Koeter ◽  
D. J. Veltman ◽  
A. H. Schene ◽  
H. G. Ruhé

BackgroundCognitive impairments are an important feature of both remitted and depressed major depressive disorder (MDD) and bipolar disorder (BD). In particular, deficits in executive functioning may hamper everyday functioning. Identifying the neural substrates of impaired executive functioning would improve our understanding of the pathophysiology underlying these disorders, and may eventually aid in discriminating between MDD and BD, which is often difficult during depression and remission. To date, mostly medicated MDD and BD subjects have been investigated, which may have influenced results. Therefore, we investigated executive functioning in medication-free depressed and remitted MDD and BD subjects.MethodWe used the Tower of London (ToL) visuospatial planning task to assess behavioural performance and blood oxygen-level dependent responses in 35 healthy controls, 21 remitted MDD, 23 remitted BD, 19 depressed MDD and nine depressed BD subjects.ResultsVisuospatial planning per se was associated with increased frontostriatal activity in depressed BD compared to depressed MDD. In addition, post-hoc analyses indicated that visuospatial planning load was associated with increased parietal activity in depressed compared to remitted subjects, and BD compared to MDD subjects. Task performance did not significantly differ between groups.ConclusionsMore severely affected, medication-free mood disorder patients require greater parietal activity to perform in visuospatial planning, which may be compensatory to maintain relatively normal performance. State-dependent frontostriatal hyperactivity during planning may be a specific BD characteristic, providing clues for further characterization of differential pathophysiology in MDD v. BD. This could potentially provide a biomarker to aid in the differentiation of these disorders.


Sign in / Sign up

Export Citation Format

Share Document